Uterine sarcoma which is originated from uterine muscle and/or connective tissues, is very rare malignant tumor and is the most lethal of all primary uterine tumors.
This study was undertaken to correlate the clinical findings, diagnoses, managements and ultimate outcome of each particluar group of uterine sarcoma at Department of Obstetrics and Gynecology in Korea University Hospital.
@ES The reaults were as follow:
@EN 1. The distribution of uterinesarcomaby histologic type was 5 cases(35.7%) for leiomyosarcoma 5 cases (35.7%)for endometrial stromal sarcoma and 4 cases (28.6%) for mixed M?lerian tumor
2. The mean age and parity were 50.8 years and 3.1.
3. The most common symptom was irregular vaginal bleeding (64.3%), and lower abdominal pain (21.4), abdominal palpable mass (14.3%) in order of frequency.
4. The distribution by FIGO clinical stage I, 35.7% for stage Ⅱ, 7.2% for stageⅢ and 21.4% for stage Ⅳ. The average survival time of each stage of disease was decreased with increasing stage.
5. The mean survival time was decreased with increasing numbers of mitotic figure per 10 high power fields.
6. The mean survival time according to histologc type was 14.5 months for leiomyosarcoma, 21.5 months for endometrial sarcoma, 5.8 months for malignant mixed M?lerian tumor, respectively.
|